Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 179 | 0.19 | Why? |
Heparitin Sulfate | 1 | 2020 | 285 | 0.18 | Why? |
Protein Engineering | 1 | 2021 | 536 | 0.18 | Why? |
Germinal Center | 1 | 2020 | 332 | 0.17 | Why? |
Antibody Formation | 2 | 2021 | 4038 | 0.17 | Why? |
Fetal Blood | 1 | 2020 | 573 | 0.16 | Why? |
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 497 | 0.16 | Why? |
Protein Domains | 4 | 2021 | 6563 | 0.15 | Why? |
Adenoviridae | 1 | 2020 | 1151 | 0.13 | Why? |
Recombinant Proteins | 2 | 2021 | 3786 | 0.13 | Why? |
Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.12 | Why? |
Lymphocyte Activation | 1 | 2020 | 2742 | 0.11 | Why? |
Antibodies, Viral | 7 | 2021 | 51949 | 0.10 | Why? |
Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
Macaca mulatta | 1 | 2020 | 3716 | 0.10 | Why? |
Placenta | 1 | 2020 | 1531 | 0.10 | Why? |
Immunoglobulin G | 6 | 2020 | 21571 | 0.09 | Why? |
Immunoassay | 2 | 2020 | 4485 | 0.09 | Why? |
Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.08 | Why? |
Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
Massachusetts | 2 | 2020 | 1279 | 0.08 | Why? |
CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.07 | Why? |
Antibodies | 2 | 2021 | 846 | 0.07 | Why? |
Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.06 | Why? |
Immunoglobulin M | 4 | 2020 | 9091 | 0.06 | Why? |
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 65 | 0.05 | Why? |
Haplorhini | 1 | 2021 | 307 | 0.05 | Why? |
Biomarkers | 2 | 2020 | 23361 | 0.05 | Why? |
Mutation | 1 | 2020 | 12376 | 0.05 | Why? |
RNA, Guide | 1 | 2021 | 269 | 0.05 | Why? |
Viral Load | 4 | 2021 | 15850 | 0.05 | Why? |
Saccharomyces cerevisiae | 1 | 2021 | 339 | 0.05 | Why? |
Antigens | 1 | 2021 | 267 | 0.05 | Why? |
Cross Reactions | 2 | 2020 | 4374 | 0.05 | Why? |
Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
Immunoglobulin A | 2 | 2020 | 3567 | 0.05 | Why? |
Peptide Library | 1 | 2021 | 564 | 0.04 | Why? |
Receptors, IgG | 1 | 2021 | 578 | 0.04 | Why? |
Dried Blood Spot Testing | 1 | 2020 | 383 | 0.04 | Why? |
Spleen | 1 | 2020 | 877 | 0.04 | Why? |
Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.04 | Why? |
Mesocricetus | 1 | 2020 | 1847 | 0.04 | Why? |
Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
Single-Domain Antibodies | 1 | 2021 | 744 | 0.03 | Why? |
Genetic Vectors | 1 | 2020 | 1600 | 0.03 | Why? |
Regression Analysis | 1 | 2020 | 2484 | 0.03 | Why? |
Male | 10 | 2021 | 367725 | 0.03 | Why? |
Cricetinae | 1 | 2020 | 3344 | 0.03 | Why? |
Disease Models, Animal | 2 | 2020 | 10998 | 0.03 | Why? |
Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
Female | 9 | 2021 | 380317 | 0.03 | Why? |
Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
Tumor Necrosis Factor-alpha | 1 | 2020 | 2483 | 0.03 | Why? |
Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
Sensitivity and Specificity | 2 | 2020 | 22971 | 0.02 | Why? |
Pneumonia, Viral | 4 | 2020 | 243684 | 0.02 | Why? |
Amino Acid Sequence | 1 | 2020 | 6049 | 0.02 | Why? |
Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
Coronavirus Infections | 4 | 2020 | 253789 | 0.02 | Why? |
Influenza A virus | 1 | 2020 | 2234 | 0.02 | Why? |
Severity of Illness Index | 3 | 2020 | 48226 | 0.02 | Why? |
Humans | 12 | 2021 | 930598 | 0.02 | Why? |
Middle Aged | 6 | 2020 | 270681 | 0.02 | Why? |
Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
Vaccines, Synthetic | 1 | 2020 | 3231 | 0.02 | Why? |
Heparin | 1 | 2020 | 2600 | 0.02 | Why? |
Molecular Dynamics Simulation | 1 | 2020 | 4155 | 0.02 | Why? |
Immunity, Cellular | 1 | 2020 | 3614 | 0.02 | Why? |
Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
Animals | 3 | 2021 | 78931 | 0.02 | Why? |
Cohort Studies | 2 | 2020 | 36005 | 0.02 | Why? |
Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
Serine Endopeptidases | 1 | 2020 | 4606 | 0.02 | Why? |
Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
Adult | 4 | 2020 | 244371 | 0.02 | Why? |
Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
Lung | 2 | 2021 | 31049 | 0.01 | Why? |
Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
Mice | 1 | 2021 | 21357 | 0.01 | Why? |
Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
Aged | 3 | 2020 | 215776 | 0.01 | Why? |
Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
Vaccination | 1 | 2020 | 19050 | 0.01 | Why? |
Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
Caradonna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(366)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_